The global AI drug discovery market is expected to grow at a compound annual growth rate of about 34 per cent to US$5.6 billion by 2029 from last year, according to Polaris Market Research. Photo: Shutterstock Images
WuXi AppTec, Warburg Pincus backed AI drug firm Insilico hopes to boost Hong Kong drug discovery sector
- Drug discovery has been unaffordable for most Hong Kong firms, but AI could change that, Insilico executive says
- Hong Kong is trying to build itself into an innovation and technology hub and will allocate US$2 billion to five major technology projects this financial year
The global AI drug discovery market is expected to grow at a compound annual growth rate of about 34 per cent to US$5.6 billion by 2029 from last year, according to Polaris Market Research. Photo: Shutterstock Images